| Literature DB >> 33022926 |
Omar Sánchez-Antonio1, Kevin A Romero-Sedglach1, Erika C Vázquez-Orta1, Eusebio Juaristi1,2.
Abstract
Novel organocatalytic systems based on the recently developed (S)-proline derivative (2S)-[5-(benzylthio)-4-phenyl-(1,2,4-triazol)-3-yl]-pyrrolidine supported on mesoporous silica were prepared and their efficiency was assessed in the asymmetric aldol reaction. These materials were fully characterized by FT-IR, MS, XRD, and SEM microscopy, gathering relevant information regarding composition, morphology, and organocatalyst distribution in the doped silica. Careful optimization of the reaction conditions required for their application as catalysts in asymmetric aldol reactions between ketones and aldehydes afforded the anticipated aldol products with excellent yields and moderate diastereo- and enantioselectivities. The recommended experimental protocol is simple, fast, and efficient providing the enantioenriched aldol product, usually without the need of a special work-up or purification protocol. This approach constitutes a remarkable improvement in the field of heterogeneous (S)-proline-based organocatalysis; in particular, the solid-phase silica-bonded catalytic systems described herein allow for a substantial reduction in solvent usage. Furthermore, the supported system described here can be recovered, reactivated, and reused several times with limited loss in catalytic efficiency relative to freshly synthesized organocatalysts.Entities:
Keywords: (S)-proline; asymmetric aldol reaction; reusable organocatalysts; supported organocatalysts
Mesh:
Substances:
Year: 2020 PMID: 33022926 PMCID: PMC7583865 DOI: 10.3390/molecules25194532
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Synthetic route for the preparation of supported organocatalyst (S)-5.
Scheme 2Optimized synthetic route for the preparation of silica-supported organocatalyst (S)-5.
Scheme 3Convergent synthetic route followed for the preparation of (S)-12 using the “in situ generation” approach.
Scheme 4Synthetic route followed to generate (2S,4R,1′S)-18 and (2S,4R,1′R)-18.
Figure 1Novel silica-supported organocatalysts synthesized in this work.
Asymmetric aldol reaction between cyclohexanone and 4-nitrobenzaldehyde in the presence of organocatalysts (S)-5, (S)-12, (2S,4R,1′S)-18 and (2S,4R,1′R)-18.
| Entry | Catalyst | Additive | Time (h) | Yield % [e] | ||
|---|---|---|---|---|---|---|
|
| Commercial silica | None | 96 | - | - | - |
|
| (S)-5 [a] | None | 20 | 78:21 | 65:35/60:40 | 98 |
|
| ( | H2O | 24 | 74:25 | 70:30/65:35 | 99 |
|
| ( | 24 | 70:30 | 85:15/60:40 | 99 | |
|
| ( | salicylic acid | 24 | 70:30 | 65:35/60:40 | 99 |
|
| ( | 36 | 76:24 | 96:4/70:30 | 99 | |
|
| ( | salicylic acid | 36 | 75:25 | 95:5/60:40 | 98 |
|
| ( | None | 36 | 75:25 | 90:10/80:20 | 99 |
|
| ( | H2O | 36 | 80:20 | 90:10/80:20 | 96 |
|
| ( | 36 | 70:30 | 90:10/60:40 | 96 | |
|
| (2 | None | 22 | 70:30 | 65:35/65:30 | 96 |
|
| (2 | None | 24 | 70:30 | 60:40/60:40 | 97 |
[a] An amount of 10 mol% of catalyst was employed; [b] 5 mol% of catalyst was employed. [c] The relative configuration was determined by 1H-NMR spectroscopy, anti: δ 4.90, dd, J = 8.4 Hz. syn: δ 5.47 ppm. [d] Absolute configuration was determined by HPLC analysis with an AD-H chiral column. [e] Following filtration. Extracted with 5 mL of EtOAc and purified in a small silica column after concentration. [f] At 1 °C. The aldehyde substrate is the limiting reagent, 37 mg (1.0 equiv.) of p-nitrobenzaldehyde. [g] Entry 1 is the control reaction; commercial silica was employed; the aldol reaction does not proceed in the absence of organocatalyst.
Scope of the asymmetric aldol reaction between cyclohexanone and aromatic aldehydes catalyzed by (S)-5.
| Entry | Product | R | Time (h) | Yield % [c] | ||
|---|---|---|---|---|---|---|
|
|
| 2-NO2 | 36 | 70:30 | 70:30 | 95 |
|
|
| 3-NO2 | 36 | 75:25 | 70:30 | 95 |
|
|
| 2-CF3 | 72 | 85:15 | 60:40 | 95 |
|
|
| 4-Cl | 48 | 70:30 | 70:30 | 94 |
|
|
| 4-CF3 | 36 | 75:25 | 65:35 | 96 |
|
|
| 4-Br | 36 | 80:20 | 80:20 | 99 |
|
|
| -H | 48 | 70:30 | 60:40 | 94 |
[a] The relative configuration was assigned by analysis of 1H-NMR coupling constants. [b] The absolute configuration was determined by HPLC analysis with chiral columns (by comparison with literature data). [c] Determined after filtration, extraction with 5 mL of EtOAc, evaporation and purification through a small silica column. The aldehyde substrate is the limiting reagent: 37 mg (1.0 equiv.) of p-nitrobenzaldehyde.
Asymmetric aldol reaction between acetone and aromatic aldehydes employing (S)-5 as catalyst.
| Entry | Product | R | Time (h) |
| Yield % [b] |
|---|---|---|---|---|---|
|
|
| 4-NO2 | 48 | 70:30 | 98 |
|
|
| 2-NO2 | 48 | 65:35 | 98 |
|
|
| 2-Cl | 48 | 65:35 | 98 |
|
|
| 4-CF3 | 36 | 60:40 | 98 |
|
|
| 4-Br | 36 | 65:35 | 97 |
|
|
| 4-Cl | 72 | 70:30 | 97 |
|
|
| 4-F | 48 | 65:35 | 99 |
|
|
| -H | 96 | 60:40 | 98 |
|
|
| 4-CH3 | 96 | 60:40 | 98 |
|
|
| 3-Br | 48 | 60:40 | 99 |
[a] Determined by HPLC analysis with chiral columns, by comparison with retention times reported in the literature. [b] Determined after filtration. Extracted with 5 mL of EtOAc and dried. [c] Determined after filtration. Extraction with 5 mL of EtOAc and purification by silica column chromatography.
Asymmetric aldol reaction between isatin derivatives and aromatic aldehydes catalyzed by (S)-5.
| Product | -R | Time (h) | Yield % [c] | ||
|---|---|---|---|---|---|
|
| -H | 10 | 70:30 | 70:30 | 88 |
|
| 5-NO2 | 9 | 75:25 | 60:40 | 85 |
|
| 7-Cl | 12 | 80:20 | 60:40 | 90 |
[a] Determined by 1H-NMR spectroscopy. [b] Determined by HPLC analysis with chiral columns. [c] Determined after extraction with 5 mL of EtOAc, concentration and purification through a small silica column.
Asymmetric aldol reaction between acetone and aromatic aldehydes employing silica-supported (S)-5 as organocatalyst.
| Cycle | Er [a] | Yield % [b] |
|---|---|---|
| 1 | 70:30 | 98 |
| 2 | 65:35 | 98 |
| 3 | 65:35 | 99 |
| 4 | 65:35 | 98 |
| 5 | 66:34 | 98 |
| 6 | 65:35 | 97 |
| 7 | 65:35 | 97 |
| 8 | 65:35 | 99 |
| 9 | 60:40 | 98 |
| 10 | 60:40 | 98 |
| 11 | 60:40 | 98 |
| 12 | 60:40 | 99 |
| 13 | 60:40 | 96 |
| 14 | 60:40 | 97 |
| 15 | 60:40 | 96 |
[a] Determined by HPLC analysis with AS-H chiral columns. [b] Determined after filtration. Extracted with 5 mL of EtOAc and dried.
Figure 2SEM and XRD imaging: A1–A3 commercial silica. B1–B3 Silica-supported organocatalyst (S)-5. C1–C3 Silica-supported organocatalyst (S)-5 after 10 catalytic cycles.